top of page

OUR PLATFORM

AgriRNA Biosciences is pioneering a new generation of programmable RNA technologies for sustainable agriculture and food systems by uniting deep RNA biology with generative artificial intelligence. Our integrated platform systematically explores RNA sequence space to precisely regulate gene expression-enabling the activation, silencing, or fine-tuning of biological pathways through RNA modalities, enzyme technologies, and advanced genetic engineering. By computationally designing optimized mRNA constructs and identifying high-confidence target regions for antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs), we deliver highly specific, scalable, and environmentally responsible solutions for agriculture and food innovation.

 

Through scientific innovation and dedication to sustainability, we're building a future where agricultural productivity and environmental responsibility go hand in hand. Our team combines expertise in biotechnology, agriculture, medical, and management fields to develop RNA-based solutions for agricultural and food industry challenges. Our goal is to enhance agriculture and dairy production through RNA technology and genetic engineering, focusing on sustainability and productivity.​

An-overview-of-the-RNA-sequencing-pipeli

We are developing a broad portfolio of agriculture and food solutions that have the potential to meaningfully improve the food crisis, human health and environmental protection.  Each of our products strictly follows the principles of our R&D strategy: selecting targets that are best target based on AI-assisted omics and in-vitro study, target selection, oligo engineering/ optimization, and preclinical study

ARNA-AI-and Biopesticde_edited.jpg

Our Proprietary Platform 

ARBP™

AgriRNA Biopest Control (ARBP™platform leverages unique AI/ML algorithms and relevant multiomics data and system biology approach to identify precision biomarkers and target molecules and de-risk accelerated drug discovery, repurposing and biomarker-based patient stratification.

ARH™

GeneCure™ is our flagship gene therapy platform that targets neurological diseases with precision and effectiveness.  We are developing gene editing technology in order to modifies diseased brain cells into vigorous cells.

Learn More

ARNA Vac™

ASOCure™ is a cutting-edge solution that addresses complex neurological conditions, providing hope for patients and families. Antisense Oligonucleotide (ASOCure™) is a Brainome proprietary platform exploited to target genetic neurological disease beyond conventional therapies.

Discover More

ARNA-AI™

RNACure™ platform leverages mRNA carrying genetic information to restore brain cell function, whereas siRNA that interfere with gene expression by causing the degradation of specific mRNA targets, leading to silencing of the gene, offering promising outcomes for patients suffering from neurological disorders.

Explore
bottom of page